A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance)Peter W. Martin, Bruce D. Cheson|Annals of Oncology|2017Cited by 82